EXAGEN INC. Research And Development Expense

Quick Answer

EXAGEN INC. reported Research And Development Expense of $6.25 million for the year ending 2025.

  • EXAGEN INC. showed an increase of +16.4% in Research And Development Expense from 2024 to 2025.
  • This data is from EXAGEN INC.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
  • XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2018 to 2025), EXAGEN INC.'s Research And Development Expense has grown by 194.3%.
  • Historical annual values: Fiscal year 2025: $6.25 million | Fiscal year 2024: $5.38 million | Fiscal year 2023: $4.87 million | Fiscal year 2022: $9.88 million | Fiscal year 2021: $7.24 million | Fiscal year 2020: $3.57 million | Fiscal year 2019: $2.18 million | Fiscal year 2018: $2.13 million.
  • Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: